| Literature DB >> 28959650 |
Hamid Arazi1, Heidar Mohammadjafari2, Abbas Asadi1,3.
Abstract
The aim of this study was to determine the effect of anabolic androgenic steroids (AAS) use on oxidative stress responses to a single session of resistance exercise in strength-trained men. Twenty-three strength trained men, with 11 self-reporting regular AAS use and 12 self-reporting never taking AAS (NAAS) volunteered to participate in this study. Blood draws were obtained pre and post resistance exercise in order to evaluate changes in oxidative stress biomarkers levels (i.e., 8-hydroxy-2-deoxyguanosine [8-OHdG], malondialdehyde [MDA], and nitric oxide [NO]), antioxidant defense systems (i.e., glutathione peroxidase [GPx] and catalase [CAT]), and glucose (GLU) levels. The AAS users had higher level of 8-OHdG (77.3 ± 17 vs. 57.7 ± 18.2 ng/mg), MDA (85.6 ± 17.8 vs. 52.3 ± 15.1 ng/mL), and GPx (9.1 ± 2.3 vs. 7.1 ± 1.3 mu/mL) compared to NAAS at pre exercise (p < 0.05). Both the experimental groups showed increases in 8-OHdG (p = 0.001), MDA (p = 0.001), GPx (p = 0.001), NO (p = 0.04), CAT (p = 0.02) and GLU (p = 0.001) concentrations after resistance exercise, and the AAS group indicated significant differences in 8-OHdG (p = 0.02) and MDA (p = 0.05) concentrations compared with NAAS users at post exercise. In conclusion, use of AAS is associated with alterations in immune function resulting in oxidative stress, and cell damage; however, high-intensity resistance exercise could increase greater oxidative stress biomarkers in strength-trained men.Entities:
Keywords: Anabolic; ROS; Strength exercise
Year: 2017 PMID: 28959650 PMCID: PMC5615127 DOI: 10.1016/j.toxrep.2017.05.005
Source DB: PubMed Journal: Toxicol Rep ISSN: 2214-7500
Participant characteristics.
| Variable | Group | |
|---|---|---|
| AAS (n = 11) | NAAS (n = 12) | |
| Age (yr) | 19.4 ± 2.3 | 20.8 ± 3.6 |
| Height (cm) | 179.5 ± 6.7 | 181.5 ± 5.5 |
| Weight (kg) | 88.1 ± 8.3 | 87.1 ± 9.4 |
| BMI (kg/m2) | 27.3 ± 2.6 | 25.9 ± 3.6 |
| Strength-training experience (yr) | 3.2 ± 2.1 | 3.2 ± 2.1 |
AAS: Anabolic-androgenic steroids, NAAS: Non AAS.
Anabolic-androgenic steroids used by participants.
| Drug | Number of Times Reported | |
|---|---|---|
| Testosterone cypionate | (Depo testosterone) | 3 |
| Nandrolone phenpropionate | (Durabolin) | 1 |
| Methandrostenolone | (Dianabol) | 2 |
| Oxandrolone | (Anavar) | 1 |
| Methenolone enanthate | (Depo premabalon) | 3 |
Oxidative stress and antioxidant changes before and after resistance exercise.
| AAS (n = 11) | NAAS (n = 12) | P value | |
|---|---|---|---|
| 8-OHdG (ng/mg) | |||
| Before | 77.3 ± 17 | 57.7 ± 18.2 | T = 0.001 |
| After | 92.9 ± 20.1 | 85.6 ± 17.8 | G = 0.005 |
| % of change | 20.1 | 48.3 | T × G = 0.02 |
| ES | 0.91b | 1.5c | |
| MDA (ng/mL) | |||
| Before | 85.6 ± 17.8 | 52.3 ± 15.1 | T = 0.001 |
| After | 101.7 ± 22.4 | 63.2 ± 19.9 | G = 0.004 |
| % of change | 18.8 | 21.1 | T × G = 0.05 |
| ES | 0.90b | 0.72b | |
| NO (μm) | |||
| Before | 4.8 ± 1.1 | 4.8 ± 2.2 | T = 0.04 |
| After | 5.6 ± 1.4 | 5.3 ± 1.4 | G = 0.83 |
| % of change | 16.6 | 10.4 | T × G = 0.41 |
| ES | 0.72b | 0.22a | |
| GPx (mu/mL) | |||
| Before | 9.1 ± 2.3 | 7.1 ± 1.3 | T = 0.001 |
| After | 11.3 ± 3.2 | 8.4 ± 1.6 | G = 0.007 |
| % of change | 24.1 | 18.3 | T × G = 0.09 |
| ES | 0.95b | 1b | |
| CAT (mu/mL) | |||
| Before | 8 ± 1.6 | 8.1 ± 1.2 | T = 0.02 |
| After | 8.7 ± 0.9 | 8.9 ± 1.9 | G = 0.81 |
| % of change | 8.7 | 9.8 | T × G = 0.89 |
| ES | 0.43a | 0.66b | |
| GLU (mg/dL) | |||
| Before | 100.6 ± 14.1 | 93.7 ± 7.2 | T = 0.001 |
| After | 115.8 ± 14.5 | 111.3 ± 8 | G = 0.06 |
| % of change | 15.1 | 18.7 | T × G = 0.7 |
| ES | 1b | 2.4d | |
AAS: Anabolic-androgenic steroids, NAAS: Non AAS, T: Time, G: Group, ES: Effect size.
a,b,c,dDenote small, moderate, large and very large ESs, respectively.